Safety of subcutaneous daratumumab in the treatment of plasma-cell disorders: A single-center experience. Kye, J., Seyer, M., Patel, S., Kim, E., Hewitt, R., Liedtke, M., Iberri, D. LIPPINCOTT WILLIAMS & WILKINS. 2021

View details for DOI 10.1200/JCO.2021.39.15_suppl.e20007

View details for Web of Science ID 000708120304213